Regression of language and non-language skills in pervasive developmental disorders.

BACKGROUND As part of the pervasive developmental disorders (PDD), there is a subgroup of individuals reported to have a different onset of symptom appearance consisting of an apparently normal early development, followed by a loss of verbal and/or non-verbal skills prior to 2 years of age. This study aims at comparing the symptomatology of children who displayed a regression and often an associated intellectual disability through investigation of two types of loss, namely language and other skill regression. METHODS This study examined the occurrence of regression in 135 children with PDD, mean age 6.3 years. The sample was composed of 80 (59.4%) children diagnosed with autism, 44 (32.6%) with pervasive developmental disorder-not otherwise specified (PDD-NOS) and 11 (8%) with Asperger syndrome. The Autism Diagnostic Interview Revised (ADI-R) was used to evaluate the type of loss and to characterise associated factors including birth rank, gender and thimerosal exposure through vaccination. RESULTS A total of 30 (22%) subjects regressed: nine (30%) underwent language regression alone, 17 (57%) lost a skill other than language and four (13%) lost both language and another skill. Significantly higher levels of regression were found in autism (30%) compared with PDD-NOS (14%) and Asperger syndrome (0%). Children who regressed in language skills spoke at a significantly earlier age ( = 12 months) than those who did not regress in this domain ( = 26 months). Parents and interviewers consistently reported developmental abnormalities prior to the loss. ADI-R domain mean scores indicated a more severe autistic symptomatology profile in children who regressed compared with those who did not, especially in the repetitive behaviour domain. Regression was not associated to thimerosal exposure, indirectly estimated by year of birth. CONCLUSIONS A loss of skill, present in one out of five children with PDD, is associated with a slightly more severe symptomatology as measured by the ADI-R, particularly in the repetitive behaviours domain. Furthermore, although abnormalities are often noticed by the caregivers at the time of regression, the ADI-R reveals that other atypical behaviours were in fact present prior to the onset of regression in most cases. None of the secondary factors investigated were associated with regression. In children unexposed to thimerosal-containing vaccines, the rate of regression was similar to that reported in studies of samples exposed to thimerosal, suggesting that thimerosal has no specific association with regressive autism.

[1]  B. Schwartz,et al.  Thimerosal-Containing Vaccines and Autistic Spectrum Disorder: A Critical Review of Published Original Data , 2004, Pediatrics.

[2]  B. Schwartz,et al.  Thimerosal-Containing Vaccines and Autistic Spectrum Disorder: A Critical Review of Published Original Data , 2005, Pediatrics.

[3]  E. Fombonne Diagnostic assessment in a sample of autistic and developmentally impaired adolescents , 1992, Journal of autism and developmental disorders.

[4]  Immunization Safety Review : Vaccines and Autism , 2004 .

[5]  N. Minshew,et al.  Effects of age on brain volume and head circumference in autism , 2002, Neurology.

[6]  J. Baio,et al.  Prevalence of Autism Spectrum Disorders: Autism and Developmental Disabilities Monitoring Network, United States, 2006. Morbidity and Mortality Weekly Report. Surveillance Summaries. Volume 58, Number SS-10. , 2009 .

[7]  Russell S Kirby,et al.  Evaluation of a methodology for a collaborative multiple source surveillance network for autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002. , 2007, Morbidity and mortality weekly report. Surveillance summaries.

[8]  G. Dawson,et al.  Is There a ‘Regressive Phenotype’ of Autism Spectrum Disorder Associated with the Measles-Mumps-Rubella Vaccine? A CPEA Study , 2006, Journal of autism and developmental disorders.

[9]  Thomas Bourgeron,et al.  Mapping autism risk loci using genetic linkage and chromosomal rearrangements , 2007, Nature Genetics.

[10]  G. Dawson,et al.  Rate of Head Circumference Growth as a Function of Autism Diagnosis and History of Autistic Regression , 2007, Journal of child neurology.

[11]  H. Kurita,et al.  Infantile autism with speech loss before the age of thirty months. , 1985, Journal of the American Academy of Child Psychiatry.

[12]  W. McMahon,et al.  Autism, regression, and the broader autism phenotype. , 2002, American journal of medical genetics.

[13]  F. Volkmar,et al.  Language regression in childhood. , 2001, Pediatric neurology.

[14]  I. Rapin,et al.  Clinical characteristics of language regression in children. , 2003, Developmental medicine and child neurology.

[15]  B. Mazer,et al.  Analysis of Clinical Features Predicting Etiologic Yield in the Assessment of Global Developmental Delay , 2006, Pediatrics.

[16]  Paula Krakowiak,et al.  Regression in autism: prevalence and associated factors in the CHARGE Study. , 2008, Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association.

[17]  S. Rogers Developmental regression in autism spectrum disorders. , 2004, Mental retardation and developmental disabilities research reviews.

[18]  C. Lord,et al.  Regression and word loss in autistic spectrum disorders. , 2004, Journal of child psychology and psychiatry, and allied disciplines.

[19]  E. Fombonne,et al.  No evidence for links between autism, MMR and measles virus , 2004, Psychological Medicine.

[20]  Eric Fombonne,et al.  Epidemiology of autistic disorder and other pervasive developmental disorders. , 2005, The Journal of clinical psychiatry.

[21]  Ruth A. Carper,et al.  Evidence of brain overgrowth in the first year of life in autism. , 2003, JAMA.

[22]  Pamela Flodman,et al.  Language and Other Regression: Assessment and Timing , 2003, Journal of autism and developmental disorders.

[23]  C P Farrington,et al.  MMR and autism: further evidence against a causal association. , 2001, Vaccine.

[24]  A. Sabrá,et al.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children , 1998, The Lancet.

[25]  T. Kemper,et al.  Neuroanatomic observations of the brain in autism: a review and future directions , 2005, International Journal of Developmental Neuroscience.

[26]  Jaroslaw Harezlak,et al.  ADHD and epilepsy in childhood. , 2003, Developmental medicine and child neurology.

[27]  L. Sears,et al.  Familial, Medical and Developmental Patterns of Children with Autism and a History of Language Regression , 2004 .

[28]  E. Fombonne,et al.  No evidence for a new variant of measles-mumps-rubella-induced autism. , 2001, Pediatrics.

[29]  N. Andrews,et al.  Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study , 2002, BMJ : British Medical Journal.

[30]  B. J. Williams,et al.  Parental report of the early development of children with regressive autism , 2005, Autism : the international journal of research and practice.

[31]  J. Mantovani Autistic regression and Landau-Kleffner syndrome: progress or confusion? , 2000 .

[32]  E. Fombonne Epidemiological Surveys of Autism and Other Pervasive Developmental Disorders: An Update , 2003, Journal of autism and developmental disorders.

[33]  Brian J Ward,et al.  No Evidence of Persisting Measles Virus in Peripheral Blood Mononuclear Cells From Children With Autism Spectrum Disorder , 2006, Pediatrics.

[34]  R. Tuchman,et al.  Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. , 1997, Pediatrics.

[35]  Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, six sites, United States, 2000. , 2007, Morbidity and mortality weekly report. Surveillance summaries.

[36]  Linyan Meng,et al.  Pervasive Developmental Disorders in Montreal, Quebec, Canada: Prevalence and Links With Immunizations , 2006, Pediatrics.

[37]  Bernard Rimland,et al.  Association between thimerosal-containing vaccine and autism. , 2003, JAMA.

[38]  A. Couteur,et al.  Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders , 1994, Journal of autism and developmental disorders.

[39]  R. Tuchman,et al.  Epilepsy in autism , 2002, The Lancet Neurology.

[40]  J. Mantovani Autistic regression and Landau‐Kleffner syndrome: progress or confusion? , 2000, Developmental medicine and child neurology.